Vaxart, Inc. (VXRT)
OTCMKTS
· Delayed Price · Currency is USD
0.760
+0.010 (1.33%)
Mar 4, 2026, 3:59 PM EST
Vaxart Employees
Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.
Employees
105
Change (1Y)
-4
Growth (1Y)
-3.67%
Revenue / Employee
$1,411,467
Profits / Employee
-$482,886
Market Cap
173.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| Nuo Therapeutics | 9 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
| ZIVO Bioscience | 7 |
| Harvard Apparatus Regenerative Technology | 8 |
Vaxart News
- 2 days ago - Vaxart to Host Upcoming Conference Calls - GlobeNewsWire
- 2 months ago - Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - GlobeNewsWire
- 3 months ago - Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript - Seeking Alpha
- 4 months ago - Vaxart, Inc. (VXRT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program - PRNewsWire
- 4 months ago - Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program - PRNewsWire
- 5 months ago - Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025 - GlobeNewsWire
- 6 months ago - Vaxart Appoints W. Mark Watson as Lead Independent Director - GlobeNewsWire